Bolt Biotherapeutics Statistics
Total Valuation
BOLT has a market cap or net worth of $9.83 million. The enterprise value is -$216,075.
Important Dates
The last earnings date was Thursday, August 14, 2025, after market close.
| Earnings Date | Aug 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BOLT has 1.92 million shares outstanding. The number of shares has increased by 0.80% in one year.
| Current Share Class | 1.92M |
| Shares Outstanding | 1.92M |
| Shares Change (YoY) | +0.80% |
| Shares Change (QoQ) | +0.03% |
| Owned by Insiders (%) | 0.63% |
| Owned by Institutions (%) | 23.25% |
| Float | 1.44M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.50 |
| Forward PS | 3.53 |
| PB Ratio | 0.27 |
| P/TBV Ratio | 0.27 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.11, with a Debt / Equity ratio of 0.62.
| Current Ratio | 3.11 |
| Quick Ratio | 2.82 |
| Debt / Equity | 0.62 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -81.33% and return on invested capital (ROIC) is -39.81%.
| Return on Equity (ROE) | -81.33% |
| Return on Assets (ROA) | -33.45% |
| Return on Invested Capital (ROIC) | -39.81% |
| Return on Capital Employed (ROCE) | -84.57% |
| Revenue Per Employee | $80,135 |
| Profits Per Employee | -$975,250 |
| Employee Count | 52 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -60.80% in the last 52 weeks. The beta is 0.90, so BOLT's price volatility has been lower than the market average.
| Beta (5Y) | 0.90 |
| 52-Week Price Change | -60.80% |
| 50-Day Moving Average | 5.89 |
| 200-Day Moving Average | 8.55 |
| Relative Strength Index (RSI) | 39.84 |
| Average Volume (20 Days) | 16,408 |
Short Selling Information
The latest short interest is 78,597, so 4.10% of the outstanding shares have been sold short.
| Short Interest | 78,597 |
| Short Previous Month | 86,937 |
| Short % of Shares Out | 4.10% |
| Short % of Float | 5.46% |
| Short Ratio (days to cover) | 3.49 |
Income Statement
In the last 12 months, BOLT had revenue of $4.17 million and -$50.71 million in losses. Loss per share was -$26.48.
| Revenue | 4.17M |
| Gross Profit | -22.32M |
| Operating Income | -53.44M |
| Pretax Income | -63.03M |
| Net Income | -50.71M |
| EBITDA | -51.83M |
| EBIT | -53.44M |
| Loss Per Share | -$26.48 |
Full Income StatementBalance Sheet
The company has $34.77 million in cash and $24.18 million in debt, giving a net cash position of $10.59 million or $5.52 per share.
| Cash & Cash Equivalents | 34.77M |
| Total Debt | 24.18M |
| Net Cash | 10.59M |
| Net Cash Per Share | $5.52 |
| Equity (Book Value) | 38.84M |
| Book Value Per Share | 20.24 |
| Working Capital | 26.03M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$51.36 million and capital expenditures -$41,000, giving a free cash flow of -$51.40 million.
| Operating Cash Flow | -51.36M |
| Capital Expenditures | -41,000 |
| Free Cash Flow | -51.40M |
| FCF Per Share | -$26.81 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -1,282.39% |
| Pretax Margin | -1,217.01% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BOLT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.80% |
| Shareholder Yield | -0.80% |
| Earnings Yield | -489.04% |
| FCF Yield | -495.65% |
Analyst Forecast
The average price target for BOLT is $47.50, which is 825.93% higher than the current price. The consensus rating is "Buy".
| Price Target | $47.50 |
| Price Target Difference | 825.93% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 17.19% |
| EPS Growth Forecast (5Y) | -9.02% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 9, 2025. It was a reverse split with a ratio of 1:20.
| Last Split Date | Jun 9, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |
